Ebanga
Ansuvimab
Listed by Emergent BioDefense Operations Lansing LLC
- Strength
- 400 mg/8mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Class
- Zaire Ebolavirus Glycoprotein-directed Antibo…
What it contains
- Ansuvimab 400 mg/8mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Zaire Ebolavirus Glycoprotein-directed Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 71655-578 |
| FDA application | BLA761172 |
| RxNorm concept | 2472156 |
| Package sizes listed | 3 |
| Marketed since | December 2020 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.